HYFT logo

MindWalk Holdings Corp.

HYFT
Healthcare|Biotechnology|US
$1.06
+0.06 (+6.00%)
Tangible Book / Share
$0.15
Cash / Share
$0.16

About

MindWalk Holdings Corp. functions as an innovative bio-native artificial intelligence firm. Its core mission involves leveraging the synergy of AI, comprehensive multi-omics data, and sophisticated laboratory investigations to accelerate the identification and advancement of biological therapeutics. Utilizing its proprietary LensAI platform and HYFT technology, the company forges partnerships with pharmaceutical and biotechnology enterprises. These collaborations are designed to diminish the inherent risks associated with drug development and to unlock new possibilities for treatments. Founded in 1983, the company adopted its current name, MindWalk Holdings Corp., in September 2025, having previously been known as ImmunoPrecise Antibodies Ltd. Its corporate headquarters are located in Austin, Texas.

Stock Price

-37.6%(1Y)
1M
-25.9%
3M
-19.1%
6M
-16.5%
YTD
-41.8%
1Y
-40.1%
3Y
-35.8%
5Y
-82.7%

Pipeline Summary

0 total trials
0
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4

Key Facts

Market Cap$49.9M
Employees74
CEOJennifer Lynne Bath
IPO DateJan 7, 2002
Beta0.78
52-Week Range$0.98 – $2.99
Avg Volume241,102
ExchangeNASDAQ

Ownership

Float90.6%
Shares Outstanding47.1M

Recent Insider Trades

Aisling Capital II LPJ
Dec 12, 2008861,826 shares
Aisling Capital II LPJ
Dec 12, 200810,412 shares
Aisling Capital II LPJ
Dec 12, 20081 shares
Aisling Capital II LPJ
Dec 12, 20081 shares
Aisling Capital II LPDISPOSED
Dec 12, 20081 shares

Peers

ALXOALX Oncology Holdings Inc.
$159.7M
ATYRaTyr Pharma, Inc.
$15.6M
BYSIBeyondSpring Inc.
$25.7M
CAMPCAMP4 Therapeutics Corporation
$254.8M
CLNNClene Inc.
$56.1M
FBIOFortress Biotech, Inc.
$61.7M
GUTSFractyl Health, Inc.
$12.3M
QNCXQuince Therapeutics, Inc.
$8.8M
Data last updated: Nov 9, 2026, 04:13 AM